Kevin J. Zaba - Apr 14, 2022 Form 4/A - Amendment Insider Report for REGAL REXNORD CORP (RRX)

Signature
/s/ Thomas E. Valentyn, as Power of Attorney
Stock symbol
RRX
Transactions as of
Apr 14, 2022
Transactions value $
$2,923
Form type
4/A - Amendment
Date filed
10/28/2022, 05:20 PM
Date Of Original Report
Apr 18, 2022
Previous filing
Feb 25, 2022
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RRX Common Stock Award $2.92K +21.2 +0.11% $137.88 18.9K Apr 14, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RRX Stock Appreciation Rights 8K Apr 14, 2022 Common Stock 8K $151.27 Direct F3
holding RRX Stock Options 3.07K Apr 14, 2022 Common Stock 3.07K $62.92 Direct F4
holding RRX Stock Options 20.2K Apr 14, 2022 Common Stock 20.2K $98.16 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents additional restricted stock units credited to the reporting person under the dividend equivalent reinvestment provision of the reporting person's outstanding restricted stock unit awards as a result of a quarterly dividend payment. The additional restricted stock units resulting from the dividend equivalent reinvestment are subject to the same terms and conditions, including vesting, as the outstanding restricted stock unit awards to which they are attributable.
F2 This amended Form 4 is being filed to correct the number of dividend equivalent units reported on the Form 4 filed on April 18, 2022.
F3 Granted as stock-settled Stock Appreciation Rights ("SARs") under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
F4 This option is currently exercisable in full.
F5 Stock Options will vest 100% on February 16, 2024.